MedTrace Logo

Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA

NCT05199792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2022-01-20

No results posted yet for this study

Summary

The purpose of this study is to compare magnetic resonance angiography (MRA) using gadoterate meglumine to clinically obtained MRA using gadobutrol. The specific aims are to show:

1. Carotid, chest, and abdomenal MRA with gadoterate meglumine has a comparable image quality and diagnostic confidence to MRA using gadobutrol.
2. Carotid, chest, and abdomenal MRA with gadoterate meglumine has a comparable accuracy for vascular lesion and stenosis detection compared to MRA using gadobutrol.

Conditions

  • Vascular Diseases

Interventions

DIAGNOSTIC_TEST

Dotarem

(Dotarem) (0.4 ml/kg (0.2 mmol/kg))

Sponsors & Collaborators

Principal Investigators

  • James Carr · Northwestern University

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-02
Primary Completion
2019-12-31
Completion
2020-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05199792 on ClinicalTrials.gov